Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.

Medtronic is one of the largest medical device makers in the world. The stock's dividend yield stands at a historically high 3.1%. Medtronic has increased its dividend annually for 47 consecutive ...

Cardiac electrophysiologist Dr. Jonathan Piccini says Medtronic's Define AFib study offers important lessons for other device ...

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

It's an honor to be a part of this process to, as a basic scientist, be able to play a small role in improving the lives of ...

Charles has served as faculty for Medtronic educational programs and ... patients must have the electrodes implanted in the brain, which has to happen while they are awake so the surgeon can ...

BrainSense™ Adaptive DBS is available to Medtronic DBS patients with Parkinson's who have been implanted with a Percept™ neurostimulator, as well as future Medtronic DBS patients. With more ...

The brain implants market is projected to grow from US$ 7.21 billion in 2022 to US$ 17.65 billion by 2030, at a CAGR of 11.8% ...

Medtronic plc (NYSE:MDT – Get Free Report) has received a consensus rating of “Hold” from the sixteen ratings firms that are ...

Medtronic plc (NYSE:MDT – Get Free Report ... Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy ...